Ekincare raises strategic investment from pharma giant MSD
HYDERABAD: Integrated
digital health
startup
EkinCare
on Tuesday said it raised a strategic, undisclosed investment led by global healthcare giant MSD (more popularly known as Merck & Co Inc of USA) through MSD IDEA Studio Asia Pacific, which is an initiative by the MSD Global Health Innovation Fund (MGHIF).
The pre-Series-C funding round also saw participation from EkinCare's existing investor, HealthQuad, which is a venture capital fund focused on healthcare innovation.
The Hyderabad-based startup, which raised a total funding of $22 million since it was founded in 2015, said it plans to utilise the fresh capital to expand its cashless OPD network and enhance AI-powered analytics to drive better
preventive care
,
chronic disease management
, and employee wellness outcomes.
Since inception, EkinCare partnered with over 1,000 companies and built a network of over 40,000 healthcare providers across India.
'Healthcare in India is at a turning point. Lifestyle diseases are on the rise, demand for preventive care is growing, and digital solutions are becoming a necessity. This investment from MSD IDEA Studio, with continued support from HealthQuad, is a visionary step forward for us. Their expertise in medicines, vaccines, and digital health, combined with our AI-driven, customer-centric approach, will help us deliver seamless, personalised healthcare to millions,' said Kiran Kalakuntla, co-founder & CEO of EkinCare.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
2025 Top Trending local enterprise accounting software [Click Here]
Esseps
Learn More
Undo
The
healthtech startup
was set up in 2015 by Kiran Kalakuntla along with Srikanth Samudrala, co-founder & CTO, and Noel Coutinho, co-founder & CBO. The startup leverages AI, data analytics, and telemedicine to make preventive healthcare personalised and accessible.
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
Master Value & Valuation with ET! Learn to invest smartly & decode financials. Limited seats at 33% off – Enroll now!
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Ahmedabad teen 2nd to die of Covid in two days
1 2 3 Ahmedabad: The city on Sunday recorded the second death of a Covid-19 positive patient within two days. An 18-year-old girl from Vinzol area, who was admitted to LG Hospital with complaints of respiratory illness, succumbed to the viral infection Sunday night. Meanwhile, Gujarat added 95 fresh Covid cases taking the total active cases to 397, according to data released by the state health department Monday. Of these, 22 are hospitalized Dr Bhavin Solanki, medical officer of Ahmedabad Municipal Corporation, confirmed the death and said that known comorbidities for the patient included cardiac issues. "We received details from the hospital. There were reports of the girl being pregnant, but we are yet to verify it. She had a hospitalisation period of about two days," he told TOI. On Saturday, a 47-year-old woman from Danilimda, who was also admitted to LG Hospital, died due to health complications. In both cases, the authorities were silent on the cause of death. Experts, however, pointed at breathlessness and pulmonary infections as possible reasons for their demise. It is notable that in this wave, more than 50% of the patients are below 50 years of age. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo In Ahmedabad, out of 140-odd cases, about 10% are below one year of age, said sources. The youngest patient was two days old, whereas another patient at Civil Hospital was eight months old, according to hospital data. It is notable that Gujarat ranks fourth in the country in terms of active cases at 338. Kerala leads the tally with 1,435 active cases as at 8 am on Monday, followed by 506 in Maharashtra, and 483 in Delhi. Some other states with high cases include West Bengal at 331 and Karnataka at 253. In 24 hours ending 8 am, Gujarat added 18 new cases, according to Covid dashboard of the Ministry of Health and Family Welfare (MoHFW). Since January 1, India has recorded 32 deaths related to Covid, according to the dashboard, including four in the past 24 hours. TOI had reported earlier that the prevalent strains in Covid positive cases in Gujarat include LF.7 in four cases, and LF.7.9 and XFG each have three cases each out of 15 positive samples analysed in the state till last week. Experts said that all are Omicron variants and so far, there has been no major threat associated with the variants with low morbidity and mortality across India. "The double season this month has caused a rise in flu-like symptoms among patients. The symptoms of Covid are no different. Covid is endemic now, and there is no need to be alarmed with rise or fall in the number of cases reported. Majority of the patients do not show any major effect due to acquired immunity," said a city-based physician.
Time of India
2 hours ago
- Time of India
IIT-BHU scientists' technology to check drug resistance of viruses
Varanasi: Scientists at Indian Institute of Technology (BHU) have developed new framework to help understand how virus evolves to evade drugs and treatments. While the technology focuses primarily on Coronavirus (SARS-CoV-2), it can also be applied to other pathogens and infectious diseases. The study, led by assistant professor at the School of Biochemical Engineering, Aditya Kumar Padhi, was published in the Biophysical Journal. The 'integrated multi-scale computational framework' combines several advanced computer-based methods including protein design, machine learning, hybrid QM/MM, and multi-scale simulations. It helps identify mutations or changes in viral proteins leading to drug resistance. The discovery comes at a time when Covid-19 cases are being reported. As the virus continues to mutate rapidly, the framework can help anticipate how it might resist treatment in future. While the current study focuses on resistance to sotrovimab, a monoclonal antibody used against SARS-CoV-2, the framework is applicable to other diseases too, including cancer and urinary tract infections. The team members of Laboratory for Computational Biology & Biomolecular Design (LCBD) contributed significantly to understanding resistance mechanisms against several other antiviral drugs and monoclonal antibodies against SARS-CoV-2. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like USDJPY đang đi lên không? IC Markets Đăng ký Undo Padhi said there were plans to make this framework freely available to scientists and doctors worldwide to support global fight against drug resistance. The research also aligns with India's national health initiatives, such as Integrated Disease Surveillance Programme (IDSP) and National Programme on Containment of Antimicrobial Resistance (AMR). "We developed this framework to address complex healthcare problems like antimicrobial resistance using integrated computational methods. Its modular design makes it suitable for a wide range of biomedical and healthcare challenges," said Padhi. IIT-BHU Director prof Amit Patra said, "Such advanced technologies reflect the scientific leadership of Indian institutions like IIT- BHU in research and innovation, particularly in tackling infectious diseases and major public health challenges. This also significantly contributes to the objectives of the key programme of the govt of India."
Time of India
3 hours ago
- Time of India
15-year-old boy critical with Covid & typhoid gets well, goes home
Kolkata: Amidst reports of a few Covid-19 related deaths across the country, no such deaths were reported from Bengal during this current spike. In fact, a 15-year-old boy who had a double infection of Covid-19 and typhoid was discharged from hospital. The teenager was admitted to Peerless Hospital on May 24 with a high-grade fever and other gastrointestinal problems. Test reports confirmed Covid-19. On Monday, four Covid-19 related deaths were reported – one each from Delhi, Tamil Nadu, Maharashtra, and Kerala. Two of the deaths were patients in their early 20s, with other existing health conditions. While the boy from Rishra had no existing health conditions, he was rushed to the Kolkata hospital with complaints of severe dehydration, loose stool, vomiting, throat pain, and a history of high-grade fever which refused to subside despite medication by local doctors. Due to the viral infection symptoms, a viral panel test was conducted. While the result was negative for all other respiratory viruses, doctors found the boy's swab samples positive for SARS-CoV-2. "We kept him in isolation and treated him for all symptoms, including severe dehydration. But we observed that while the other symptoms were getting resolved with medication, the fever was not persisting," said paediatrics critical care specialist Saheli Dasgupta, under whom the boy was admitted in Peerless Hospital. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Descubra ofertas de voos imperdíveis Voos | Anúncios de Pesquisa Saiba Mais Undo Suspecting some secondary infection, his blood samples were sent to the lab for blood culture, and the boy was found to have a typhoid infection. "Since the fever was persisting and a few other symptoms were not matching with Covid-19 alone, we had to look for the presence of other infections. The blood culture confirmed typhoid. This was a clear case of dual infection of Covid-19 and typhoid, and we had to take all precautions so that we continued the treatment for both infections," added Dasgupta. Experts said that even during the two waves of the Covid pandemic, many children were found infected. But unlike in adults, the infection was generally mild in children. However, dual infection could be risky for both children and adults. There have been several cases of Covid-19 with dual infections, including those of dengue, malaria, and scrub typhus, where doctors have to be extra careful in treating those patients. The 15-year-old recovered during the treatment and was discharged from hospital after seven days with the advice to stay in isolation for at least seven more days. Sources said that the father, who brought the boy to the hospital, also tested positive for Covid-19, but he is in home isolation and has only mild symptoms.
